Chargement en cours...
Elderly patients are at greater risk of cytopenia during antiviral therapy for hepatitis C
The results of antiviral therapy for hepatitis C virus (HCV) have improved recently with the use of pegylated interferon (PEG-IFN)/ribavirin (RBV) combination therapy. At this point, most patients with chronic HCV remain untreated. Thus, it is anticipated that therapy will be more appealing and pres...
Enregistré dans:
Auteurs principaux: | , , , |
---|---|
Format: | Artigo |
Langue: | Inglês |
Publié: |
Pulsus Group Inc
2006
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2659944/ https://ncbi.nlm.nih.gov/pubmed/17001400 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|